Inhibitory and activatory receptors for HLA class I molecules in human natural killer cells

Chemical Immunology

Volumn 64, Issue , 1996, Pages 77-87

  Moretta, Alessandro ^b,c   Vitale, Massimo ^a   Sivori, Simona ^c   Morelli, Luigia ^c   Pende, Daniela ^a   Bottino, Cristina ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; LYMPHOCYTE RECEPTOR;

HLA SYSTEM; HUMAN; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW;

EID: 0029840974     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319334     Document Type: Review

References (50)

1. Herberman RB, Nunn ME, Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumours. I. Distribution of reactivity and specificity. Int J Cancer 1976; 16:216-229.
2. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989;47:187-176.
3. Bancroft GJ: The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 1993;5:503-510.
4. Ljunggren H-G, Kärre K: In search of the 'missing self'. MHC molecules and NK cell recognition Immunol Today 1990;11:237-244.
5. Kärre K: An unexpected petition for pardon Curr Biol 1992; 11:613-616.
6. Moretta L, Ciccone E, Moretta A, Höglund P, Öhlen C, Kärre K: Allorecognition by NK cells: Nonself or no self? Immunol Today 1992;13:300-306.
7. Ljunggren HG, Kärre K: Host resistance directed selectively against H-2-deficient lymphoma variants: Analysis of the mechanism. J Exp Med 1985;162:1745-1759.
8. Piontek GE, Taniguchi K, Ljunggren H-G, Gronberg A, Kiessling R, Klein G, Kärre K: YAC-I MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. J Immunol 1985;135: 4281-4288.
9. Kärre K. Ljunggren H-G, Piontek G, Kiessling R: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 1986;319:675-678.
10. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L: Receptors for HLA-class I molecules in human natural killer cells. Annu Rev Immunol 1996;14:619-648
11. Pantaleo G, Zocchi MR, Ferrini S, Poggi A, Tambussi G, Bottino C, Moretta L, Moretta A: Human cytolytic cell clones lacking surface expression of T cell receptor α/β or γ/δ. Evidence that surface structures other than CD3 or CD2 molecules are required for signal transduction. J Exp Med 1988; 168:13-24.
12. Ciccone E, Pende D, Viale O, Di Donato C, Tripodi G, Orengo AM, Guardiola J, Moretta A, Moretta L: Evidence of a natural killer (NK) cell repertoire for (allo)antigen recognition. Definition of five distinct NK-determined allospecificities in humans. J Exp Med 1992,175.709-718.
13. Moretta L, Ciccone E, Mingari MC, Biassoni R, Moretta A: Human NK cells: Origin, clonality, specificity and receptors. Adv Immunol 1994;55:341-380.
14. Ciccone E, Pende D, Viale O, Tambussi G, Ferrini S, Biassoni R, Longo A, Guardiola J, Moretta A, Moretta L: Specific recognition of human CD3-Cd16+ NK cells required the expression of an autosomic recessive gene on target cells. J Exp Med 1990;172.47-52.
15. Ciccone E, Pende D, Viale O, Di Donato C, Orengo AM, Biassoni R, Verdiani S, Amoroso A, Moretta A, Moretta L Involvement of HLA class I alleles in NK cell-specific functions: Expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 1992;176:963-971.
16. Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Augugliaro R, Barbaresi M, Ciccone E, Moretta L P58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities J Exp Med 1993;178:597-604.
17. Christiansen FT, Witt CS, Ciccone E, Townend D, Pende D, Viale O, Abraham LJ, Dawkins RL, Moretta L: Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: Ancestal haplotypes encode particular NK-defined haplotypes. J Exp Med 1993;178:1033-1039.
18. Colonna M, Spies T, Strominger JL, Ciccone E, Moretta A, Moretta L, Pende D, Viale O: Alloantigen recognition by human natural killer cells is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci USA 1992;89:7983-7985.
19. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, Conte R, di Donato C, Parham P, Moretta L: Amino acid substitutions can influence the NK-mediated recognition of HLA-C mojecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by 'group 2' or 'group 1' NK clones J Exp Med 1995;182:605-609.
20. Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, Barbaresi M, Pende D, Ciccone E, Lopez-Botet M, Moretta L: Human natural killer cell receptors for HLA-class I molecules Evidence that the Kp43 (CD94) molecules functions as receptor for HLA-B alleles. J Exp Med 1994;180:545-555.
21. Litwin V, Gumperz JE, Parham P, Phillips JH, Lamer LL: NKB1: A natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules J Exp Med 1994;180:537-543.
22. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M: NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 1994;180.1235-1242.
23. Gumperz JE, Litwin V, Phillips JG, Lanier LL, Parham P: The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995;181:1133-1144.
24. Vitale M, Sivori S, Pende D, Augugliaro R, di Donato C, Amoroso A, Malnati M, Bottino C, Moretta L, Moretta A: Physical and functional independency of p70 and p58 NK cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci USA, in press.
25. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL: Specificity of HLA class I antigen recognition by human NK clones: Evidence for clonai heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J Exp Med 1993;178:1321-1336.
26. Moretta A, Bottino C, Pende D, Tripodi G, Tambussi G, Viale O, Orengo A, Barbaresi M, Merli A, Ciccone E, Moretta L: Identification of four subsets of human CD3-CD16+ NK cells by the expression of clonally distributed functional surface molecules. Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990; 172:1589-1598
27. Moretta A, Tambussi G, Bottino C, Tripodi G, Merli A, Ciccone E, Pantaleo G, Moretta L: A novel surface antigen expressed by a subset of human CD3-CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med 1990;171:695-714.
28. Ick kinase. Eur J Immunol 1994;24:2527-2534.
29. Vitale M, Sivori S, Pende D, Moretta L, Moretta A: The coexpression of two functionally independent p58 inhibitory receptors in human NK cell clones results in the inability to kill all normal allogeneic target cells Proc Natl Acad Sci USA 1995,92:3536-3540
30. Raulet DH, Held W: Natural killer cell receptors: The offs and ons of NK cell recognition, Cell 1995;82:697-700.
31. Vaage JT, Naper C, Lovik G, Lambracht D, Rehm A, Hedrich HJ, Wonigeit K, Rolstad B: Control of rat natural killer cell-mediated allorecognition by a major histocompatibility complex region encoding nonclassical class I antigens. J Exp Med 1995;180:640-651.
32. Naper C, Vaage JT, Lambracht D, Lovik G, Butcher GW, Wonigeit K, Rolstad B: Alloreactive natural killer cells in rat: Complex genetics of major histocompatibility complex control. Eur J Immunol 1995,25.1249-1256.
33. Öhlen C, Höglund P, Sentman CL, Carbone E, Ljunggren HG, Koller B, Kärre K: Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Eur J Immunol 1995;25:1286-1291.
34. Bennet M, Lawrence YY, Stoneman E, Rembecki RM, Mathew PA. Fisher Lindahl K, Kumar V: Hybrid resistance: 'negative' and 'positive' signaling of murine natural killer cells. Semin Immunol 1995;7:121-127.
35. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L: Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995;182:875-884.
36. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both extra- and intracellular domains. Immunity 1995;2:439-449.
37. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L: The HLA-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions J Exp Med, in (press).
38. Aramburu J, Balboa MA, Ramirez A, Silva A, Acevedo A, Sancez-Madrid F, de Landàzuri MO, Lòpez-Botet M: A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-γ/δ+T lymphocytes. Inhibition of IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol 1995;44:3238-3247.
39. Aramburu J, Balboa MA, Izquierdo M, López-Botet M: A novel functional cell surface dimer (KP43) expressed by natural killer cells and TCR T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monclonal antibody. J Immunol 1991;147:714-721.
40. Aramburu J, Balboa MA, Rodrìguez A, Melero I, Alonso M, Alonso JL, Lopez-Botet M: Stimulation of IL-2 activated natural killer cells through the Kp43 surface antigen up-regulates TNF-α production involving the LFA-1 integrin. J Immunol 1993;151:3420-3429.
41. Feréz-Villar JJ, Melero I, Rodriguez A, Carretero M, Aramburu J, Sivori S, Orengo AM, Moretta A, Lòpez-Botet M: Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J Immunol 1995;154:5779-5788.
42. Sivori S, Vitale M, Sanseverino S, Parolini S, Barbaresi M, Bottino C, Moretta A: Inhibitory CD94 molecules identified by the Z199 MAb recognize different HLA-class I molecules. Transplantation, in press.
43. Yokoyama WM, Seaman WE: The Ly49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex. Annu Rev Immunol 1993;11 613-635.
44. Kane KP: Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J Exp Med 1994;179:1001-1015.
45. Sentman CL, Hackett J Jr, Kumar V, Bennet M: Identification of a subset of murine natural killer cells that mediated of Hh-1d but not Hh-1b bone marrow grafts. J Exp Med 1989;170:191-197
46. Mason L, Giardina SL, Haecht T, Ortaldo J, Mathieson BJ: LGL-1: A nonpolymorphic antigen expressed on a major population of mouse natural killer cells. J Immunol 1988;140.4403-4412.
47. Chang C, Rodriguez A, Carretero M, Lòpez-Botet M, Phillips JH, Lanier LL: Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol, in press.
48. Correa I, Raulet DH: Binding of diverse peptides to MHC class I molecule inhibits target cell lysis by activated natural killer cells. Immunity 1995,2:61-67.
49. Malnati MS. Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO: Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995,267:1016-1018.
50. Karre K: Express yourself or die: Peptides, MHC molecules, NK cells. Science 1995;267:978-979.